These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9686562)

  • 1. Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody.
    Wittig B; Schwärzler C; Föhr N; Günthert U; Zöller M
    J Immunol; 1998 Aug; 161(3):1069-73. PubMed ID: 9686562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice.
    Farkas S; Hornung M; Sattler C; Anthuber M; Gunthert U; Herfarth H; Schlitt HJ; Geissler EK; Wittig BM
    Clin Exp Immunol; 2005 Nov; 142(2):260-7. PubMed ID: 16232212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases.
    Wittig B; Seiter S; Schmidt DS; Zuber M; Neurath M; Zöller M
    Lab Invest; 1999 Jun; 79(6):747-59. PubMed ID: 10378517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice.
    Katchar K; Kelly CP; Keates S; O'brien MJ; Keates AC
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1263-71. PubMed ID: 17272517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
    Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
    Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).
    Wittig BM; Johansson B; Zöller M; Schwärzler C; Günthert U
    J Exp Med; 2000 Jun; 191(12):2053-64. PubMed ID: 10859330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.
    Neurath MF; Fuss I; Pasparakis M; Alexopoulou L; Haralambous S; Meyer zum Büschenfelde KH; Strober W; Kollias G
    Eur J Immunol; 1997 Jul; 27(7):1743-50. PubMed ID: 9247586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
    Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
    J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice.
    Lúdvíksson BR; Strober W; Nishikomori R; Hasan SK; Ehrhardt RO
    J Immunol; 1999 Apr; 162(8):4975-82. PubMed ID: 10202045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
    Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
    Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to schistosome eggs protects mice from TNBS-induced colitis.
    Elliott DE; Li J; Blum A; Metwali A; Qadir K; Urban JF; Weinstock JV
    Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G385-91. PubMed ID: 12431903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
    Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
    Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria.
    Hoffmann U; Heilmann K; Hayford C; Stallmach A; Wahnschaffe U; Zeitz M; Günthert U; Wittig BM
    Cell Death Differ; 2007 Aug; 14(8):1542-51. PubMed ID: 17479111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.
    Fiorucci S; Mencarelli A; Palazzetti B; Distrutti E; Vergnolle N; Hollenberg MD; Wallace JL; Morelli A; Cirino G
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13936-41. PubMed ID: 11717450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.